PubMed Health⌕ Search

Biomedical subjects

A S Barchuk

Publications and source records attributed to A S Barchuk.

At least 19 recordsLinked to original sources

[Diagnosis and treatment of lung cancer associated with paracancerous changes in the thoracic cavity].

Incidence of lung cancer associated with secondary paracancerous changes is known to range 13.7-30%. Since they reveal such clinical symptoms as pneumonia or empyema, most out-patients with complicated cancers are referred to general wards. Inflammatory parenchymal pathology may be conducive to false-positive or -negative diagnosis even when highly-sophisticated radiation procedures are used.

Aged↗

Phase I/II trial of gene therapy with autologous tumor cells modified with tag7/PGRP-S gene in patients with disseminated solid tumors: miscellaneous tumors.

BACKGROUND: The use of genetically modified autologous tumor cells appears to be a promising approach for cancer therapy. A phase I/II trial was undertaken to define the feasibility, safety and antitumor effects of the autologous vaccine prepared by transferring tag7/PGRP-S gene into malignant melanoma and renal cell carcinoma cells. PATIENTS AND METHODS: Twenty-one patients (17 with disseminated malignant melanoma and four with metastatic renal cell carcinoma) were enrolled in this study. Cytoreduction was performed in all cases prior to therapy. Autologous tumor cells were transfected with the tag7/PGRP-S gene, irradiated and injected intradermally every 3 weeks. RESULTS: Vaccinations were well tolerated by all patients, without clinically significant signs of toxicity. Delayed-type hypersensitivity was observed in 48% of cases. Antitumor immune response was observed in 95% of patients. There were no complete or partial responses; however, a minor response was achieved in one patient with renal cell carcinoma. The stabilization of neoplastic disease was observed in eight patients (seven with malignant melanoma and one with renal cell carcinoma). Median time to tumor progression was 3 months. CONCLUSIONS: The approach suggested here appears to be well tolerated and produces a number of durable clinical effects. Further studies are required to determine whether promising effects on immune activation will result in an actual clinical benefit for patients with malignant melanoma and renal cell carcinoma.

Adult↗

[Immediate results of pulmonary resection carried out for lung cancer in patients older than 70 years].

Pulmonary resection was carried out for lung cancer in 155 patients aged more than 70 yrs (1970--2002). Operative mortality was 19.3%. Out of 142 male survivors, 30 (21.1%) died later, while none did out of 13 female survivors. Post-operative mortality fell from 21.4% within the first decade to 13.8% in the third one. Particularly marked decrease was registered in the 70-72 year bracket--from 32.6% (1970--1981) to 6.9% (1992--2002). However, no progress was reported in patients aged more than 75 yrs. Among the main causes of lethality were acute cardio-vascular insufficiency and lung artery thromboemboly.

Aged↗

[Immediate results of pneumonectomies in lung cancer patients older than 70 years].

During 1970-2002 pneumonectomy for lung cancer was fulfilled on 155 patients older than 70 years of age. Immediate postoperative lethality took place in 19.3%. From 142 male patients after pneumonectomy 30 (21.1%) patients died, from 13 female patients - nobody died. The whole time was divided into 3 periods 10 years each. It was noted that postoperative lethality decreased from 21.4% in the first period to 13.8% - in the third one. Lethality was substantially decreased in patients aged 70-72 from 32.6% in 1970-1981 to 6.9% in 1992-2002. In patients older than 75 lethality failed to decrease. The main causes of lethal outcomes were acute cardio-vascular insufficiency and thromboembolism of the pulmonary artery.

Age Factors↗

[An improved procedure for autologous gene-modified cancer vaccine preparation for active specific immunotherapy of disseminated solid tumors].

Resected material was used from 108 patients with disseminated skin melanoma and 47 patients suffering metastasized renal tumors to test procedures of tumor cell culture preparation and to search the best parameters. Gene tag 7 transfer, liposome delivery and electroporation were employed to stimulate immunogenic tumor cells. The transfer results were evaluated by expression of beta-galactosidase and EGFP genes whose products were detected microscopically. Transfer efficiency was boosted by 30% due to selecting suitable parameters of tumor cell modification. Maximum effectiveness was attained by individualized choice of the parameters. Yet, undoubtedly, the best way of cell isolation was mechanical fragmentation of tumor. To speed up cell production, DMEM/F12 medium should be recommended. It should contain cattle embryonic serum (20%), conditioned medium of cultured fibroblasts of human embryonic lungs (20%), transferin, insulin and selenium (standard dose).

Cancer Vaccines↗

[Phase I-II trial of gene therapy with tag-7 modified autologous tumor cells in patients with metastatic solid tumors].

A prospective (phase I-II) trial was undertaken to study the efficacy and toxicity of gene therapy with tag 70-modified autologous tumor cells in 32 patients with metastatic renal cell carcinoma (RC) (5) and melanoma (MBL) (27) treated at the Institute's Clinic (2001-2003). Resected material was reduced to cell culture, which was transfected with tag 70 gene and devitalized by irradiation. Immune blotting was used for gene expression. Clinical and immunological effectiveness was evaluated in 22 patients (MBL--17 and RC--5) who received 1-6 injections (3 on the average). Full course of vaccination was given to 8 (MBL--6 and RC--2). No complete or partial response was reported while least regression (50%) was registered in a case of RC metastatic to the lung. According to CT and ultrasound evidence, stabilization was achieved in 5 (23.8%) (MBL--4 and RC--1). Relapse-free period was 6.5+/-3.5 months beginning from the start of treatment. The vaccine was well tolerated while DHT reaction was observed in 47.6% (10 out of 17) of primary immunized patients. A trend of increased content of T- and B-cells in peripheral blood and intensified functional activity was established.

Adult↗

[The factors of disease-free survival in patients with nodal metastases of cutaneous melanoma].

The time between primary lesion excision to lymphadenectomy for cutaneous melanoma was determined in 550 patients. Maximum relapse-free interval was 17.8 years, mean--16.4 months, with median time of 6.2 months. We used retrospective multivariate analysis of the time for metastases to the regional lymph nodes with such variables as sex, age at tumor presentation, site, volume of tumor or largest nodular metastasis, number of involved nodes, satellites, Breslow thickness, ulceration, epithelioid-cell presence, pigmentation, mitotic index, spontaneous tumor regression, invasive growth (Clark), and lymphoid infiltration. A retrospective univariate analysis involved such significant predictors as spontaneous tumor regression (p(0.00001), logarithm of primary tumor volume (p=0.0005), sex (p=0.0007), tumor site (p=0.008), satellites (p=0.011), and Clark's index (p=0.025). Cox's multivariate analysis established a relationship between relapse-free time and such variablesas spontaneous tumor regression (p(0.00001), logarithm of primary tumor volume (p=0.0006), tumor site (p=0.016), logarithm of volume of largest nodular metastasis (p=0.019), and sex (p=0.032).

Adult↗

[Influence of growth rates of local recurrences and in-transit metastases on survival of patients with cutaneous melanoma].

The growth rates of local recurrences and in-transit metastases of skin melanoma were assessed in 271 patients. Median growth rate in the course of chemotherapy was 0.02 a day--1 which corresponded to a doubling time of 34.7 days. Median survival time for patients with local recurrences and in-transit metastases was 22.6 months, 12-month survival--70.1%, 5-year--19.6% and 10-year--9.9%. Growth rate appeared to be the most significant prognostic factor; similarly important were tumor volume, relapse-free interval, tumor mitotic rate, site and number of recurrences. The following additional characteristics of tumor growth rate have been suggested: maximum growth rate and doubling time limit, to assess the rates of secondary tumor focus development.

Adult↗

[Rationale for surgical treatment of cancer of the lower pulmonary lobe with consideration for regional metastatic spread].

Optimal extent of surgery for lung cancer is determined to a great degree by lymph drainage and regional metastases vis-a-vis tumor localization in the lobes. Data on surgical treatment of 505 cases of cancer of the lower lobe are presented. The study established such peculiarities of metastatic spread to mediastinal lymph collector as relatively frequent involvement of the lower mediastinal lymph nodes ("jumping" metastases included) and greater likelihood of spread to the superior mediastinal lymph nodes when those of radix pulmonis are involved. The latter should be interpreted as an indicator of lower lobe involvement. We established the significance of relatively worse prognosis for mediastinal lymph node involvement as well as high frequency of intrasternal recurrences of tumors located in the left lung. The prevailing evidence on partial resections of the right lung rather than lower bilobectomy and the good results of bilobectomies for stage T1-3N1-2 tumors suggest that conservative treatment might offer more advantage in managing cancer of the lower lobe of the right lung. Extended surgery entails lower incidence of intrasternal recurrence and is more effective when used to treat right-lung tumors.

Adult↗

[Chemotherapy in combination with laser coagulation or interstitial hyperthermia--effective combined therapy for disseminated skin melanoma].

Thirty-eight patients with disseminated skin melanoma received chemotherapy in conjunction with laser coagulation or interstitial hyperthermia of intra- or subcutaneous metastases. Use of combination therapy was followed by a rise to 37% in total response and 16%--complete regression, respectively. Most effectiveness was attained when the dacarbazine + cisplatin + BCNU + tamoxifen regime was employed. In this group of 16 patients (46%), total response was 56% and, what is most significant, 31% in complete regression. In all cases of apparent response, polychemotherapy was administered both before and after laser coagulation or interstitial hyperthermia.

Adult↗

[Clinical and morphologic correlations in bronchoalveolar cancer].

Bronchioloalveolar carcinoma is a variety of lung adenocarcinoma featuring peculiar morphological pattern, period of latency, long symptom-free course, no association with smoking, younger age of victims and prevalent frequency in women. While there are no reliable diagnostic criteria, radical surgery has good prognosis (3-year overall or relapse-free survival is 88.9 and 66.7%, respectively). Prognostically significant are such morphological subtypes as mucigenous and non-mucigenous carcinoma. The study included patients with stage I and II carcinoma. Regional dissemination incidence was significantly lower than in other varieties of lung adenocarcinoma.

Adult↗

[Quantitative growth characteristics of pulmonary metastases in cutaneous melanoma].

The dynamics of growth of skin melanoma metastases to the lung versus chemoimmunotherapy regime has been assessed quantitatively. Natural course of such pathology at advanced stages was found to correspond to the exponent. An analytical procedure for plotting graphs was suggested, which will allow to estimate the kinetic characteristics of tumor growth. This in turn can be used as an indicator of therapy efficacy.

Adult↗

[Polymorphism of the GSMT1 gene in lung cancer resistance and susceptibility].

The published studies of onco-associated genetic polymorphisms are characterized by insufficient interlaboratory reproducibility. The inconsistency of the results can be partially attributed to some characteristics of patients and control groups, which are used for the comparison of allele frequencies. For instance, many investigations involve so-called "healthy donors" as a standard. However, the efficiency of such a comparison can be questioned; indeed, as an individual life-time risk of malignancy reaches as high as 40-50%, a significant part of "healthy donors" would soon or later become the oncological patients. Here we tested the advantage of using "true" oncologically tolerant individuals as an additional control, e.g. tumor-free people, who succeeded to achieve an elderly age without signs of any neoplastic disease. GSTM1 gene polymorphism was used as a "positive control" for this novel design of molecular epidemiological study, as the GSTM1-null genotype displays slight but reproducible association with lung cancer risk. In the present investigation, GSTM1-deficiency was detected in 45% elderly tumor-free individuals, 55% healthy middle-aged donors, and 59% lung cancer patients. The minimal frequency (43%) of GSTM1(-) genotype was detected in elderly tumor-free smokers, and the maximal one (100%) was found in never-smoking lung cancer patients. Thus, the comparison of lung cancer patients to the "true" oncologically tolerant cohort (elderly tumor-free individuals, especially smokers) revealed more demonstrative deviations for the unfavorable genotype, than the traditional comparative analysis between oncological patients and healthy donors.

Aged↗